US Broker Ratings

Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a Potential 72% Upside in the Healthcare Sector

Dynavax Technologies Corporation (NASDAQ: DVAX) is drawing investor attention with its promising growth prospects in the healthcare sector. As a commercial-stage biopharmaceutical company, Dynavax is focused on the development and..

Harrow, Inc. (HROW) Stock Analysis: Healthcare Potential with 43% Upside

Harrow, Inc. (NASDAQ: HROW), a Nashville-based eyecare pharmaceutical company, has been making waves in the healthcare sector, with a particular focus on ophthalmic pharmaceutical products. The company’s recent transition from..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Challenges with a 7.46% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a significant player in the U.S. healthcare sector, operates within the medical care facilities industry. With a market capitalization of $2.56 billion, Brookdale is..

Vericel Corporation (VCEL) Stock Analysis: A 47% Upside Potential Beckons Investors

Vericel Corporation (NASDAQ: VCEL) presents an intriguing opportunity for investors seeking growth in the healthcare sector. With a market capitalization of $1.89 billion, this biotechnology firm is making significant strides..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 62.58% Upside Potential

Investors with a keen eye on the healthcare sector, particularly the biotechnology industry, may find Innoviva, Inc. (NASDAQ: INVA) a compelling opportunity. This U.S.-based company, with a market cap of..

Organon & Co. (OGN) Stock Analysis: Exploring the 34% Potential Upside Amidst a Mixed Market Sentiment

For investors keen on healthcare stocks, Organon & Co. (NYSE: OGN) presents a fascinating case. This pharmaceutical company, with a market cap of $1.81 billion, operates in the general drug..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 14.2% Potential Upside in Specialty Pharmaceuticals

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands as a notable player in the healthcare sector, specializing in non-opioid pain management solutions. Headquartered in Tampa, Florida, the company is engaged in the..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Unveiling a 170% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a notable player in the healthcare sector, specializes in developing innovative treatments for rare diseases. With a market capitalization of $1.6 billion, this Durham, North..

MannKind Corporation (MNKD) Stock Analysis: A Biotech with 60% Upside Potential

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, is garnering significant attention from investors due to its promising growth prospects. With a market capitalization of $1.84 billion,..

AtriCure, Inc. (ATRC) Investor Outlook: Evaluating a 25.65% Upside Potential with Strong Buy Ratings

AtriCure, Inc. (ATRC), a prominent player in the medical instruments and supplies industry, is capturing attention with its strong growth metrics and compelling analyst ratings. Headquartered in Mason, Ohio, AtriCure..

LivaNova PLC (LIVN) Stock Analysis: Exploring a Robust 12% Potential Upside in the Medical Device Sector

Investors eyeing opportunities in the healthcare sector may find LivaNova PLC (NASDAQ: LIVN) an intriguing prospect. This UK-based medical device company, with a market capitalization of $3.44 billion, is making..

ICU Medical, Inc. (ICUI) Stock Analysis: Potential 21.91% Upside with Strong Buy Ratings

Investors seeking opportunities in the healthcare sector may find ICU Medical, Inc. (NASDAQ: ICUI) a compelling choice, given its robust potential upside and solid analyst ratings. The company, specializing in..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 30% Potential Upside Amid Robust Revenue Growth

U.S. Physical Therapy, Inc. (NYSE: USPH) is a notable player in the healthcare sector, specifically within the medical care facilities industry. Based in Houston, Texas, this company is distinguished by..

Phreesia, Inc. (PHR) Stock Analysis: A Potential 81% Upside with Strong Buy Consensus

Phreesia, Inc. (PHR) is making waves in the healthcare sector, specifically within the health information services industry. With a market capitalization nearing the billion-dollar mark at $992.93 million, Phreesia is..

Galapagos NV (GLPG) Stock Analysis: Can This Belgian Biotech Power Through a Potential -14.32% Downside?

Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, is navigating turbulent waters in the healthcare sector. With a market capitalization of $2.14 billion, the company is focused on developing innovative..

Mesoblast Limited (MESO) Stock Analysis: Exploring an 80% Upside Potential in Regenerative Medicine

Mesoblast Limited (NASDAQ: MESO) stands as a compelling player in the biotechnology sector, particularly in the niche of regenerative medicine. Headquartered in Melbourne, Australia, Mesoblast is carving a unique path..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Growth Amidst Healthcare Challenges

Pediatrix Medical Group, Inc. (NYSE: MD), a key player in the healthcare sector, specializes in neonatal and maternal-fetal care, providing critical services to vulnerable populations across the United States. With..

Disc Medicine, Inc. (IRON) Stock Analysis: Analyst Buy Ratings and 52.96% Potential Upside Capture Investor Attention

Disc Medicine, Inc. (NASDAQ: IRON) has emerged as a fascinating prospect within the healthcare sector, particularly in the burgeoning biotechnology industry. With a market capitalization of $3 billion, this clinical-stage..

IDEAYA Biosciences, Inc. (IDYA)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds